Anorectic effect and brain concentrations of D-fenfluramine in the marmoset: relationship to the in vivo and in vitro effects on serotonergic mechanisms
- PMID: 8479546
- DOI: 10.1007/BF00167450
Anorectic effect and brain concentrations of D-fenfluramine in the marmoset: relationship to the in vivo and in vitro effects on serotonergic mechanisms
Abstract
The present study investigated the anorectic activity of d-fenfluramine (d-F) and the relationship with brain levels of unchanged drug and its metabolite d-norfenfluramine (d-NF) in marmosets, relating them to neurochemical effects on the serotoninergic system. d-F and d-NF were equally active in reducing food intake (ED50 about 3 mg/kg, p.o.). However, the brain concentrations of the metabolite required to reduce food intake after synthetic d-NF were more than twice those after d-F, indicating that d-NF contributes to but does not completely explain the anorectic effect of d-F. At this dose d-F did not appreciably modify the serotonin (5-HT) and 5-hydroxyindoleacetic (5-HIAA) contents of the brain regions examined, except for a slight enhancement of 5-HIAA in hippocampus. In vitro in brain cortical synaptosomes d-F inhibited [3H]5-HT uptake more potently than d-NF, as in other species. d-F and d-NF showed similar potency in stimulating [3H]5-HT release, in a Ca++ dependent manner. The tritium released by d-F and d-NF appeared to be mainly unmetabolized [3H]5-HT. Like in other species the marmoset too has saturable and specific [3H]d-F binding sites, for which d-NF has lower affinity. d-F and d-NF have low affinities for 5-HT receptor subtypes, except that d-NF has appreciable affinity for 5-HT1C and 5-HT1D receptors. Unlike in rodents but similarly to primates in the striatum the pharmacology of 5-HT receptors seems to correspond to the 5-HT1D subtype.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat.Naunyn Schmiedebergs Arch Pharmacol. 1996 May;353(6):641-7. doi: 10.1007/BF00167183. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8738297
-
Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms.J Neurochem. 1983 Mar;40(3):891-3. doi: 10.1111/j.1471-4159.1983.tb08065.x. J Neurochem. 1983. PMID: 6827286
-
Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?Br J Pharmacol. 1982 Mar;75(3):525-30. doi: 10.1111/j.1476-5381.1982.tb09169.x. Br J Pharmacol. 1982. PMID: 6175368 Free PMC article.
-
Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.Int J Obes Relat Metab Disord. 1992 Dec;16 Suppl 3:S43-50. Int J Obes Relat Metab Disord. 1992. PMID: 1338321 Review.
-
From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake.Ann N Y Acad Sci. 1987;499:156-66. doi: 10.1111/j.1749-6632.1987.tb36207.x. Ann N Y Acad Sci. 1987. PMID: 2440376 Review.
Cited by
-
In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat.Naunyn Schmiedebergs Arch Pharmacol. 1996 May;353(6):641-7. doi: 10.1007/BF00167183. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8738297
-
Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.Drugs. 1996 Nov;52(5):696-724. doi: 10.2165/00003495-199652050-00007. Drugs. 1996. PMID: 9118819 Review.
-
Effect of d-fenfluramine on the indole contents of the rat brain after treatment with different inducers of cytochrome P450 isoenzymes.Psychopharmacology (Berl). 1995 Mar;118(2):188-94. doi: 10.1007/BF02245839. Psychopharmacology (Berl). 1995. PMID: 7617807
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous